B. Felding-Habermann

发表

Contribution of platelets to tumour metastasis

Laurie J. Gay, B. Felding-Habermann, B. Felding‐Habermann, 2011, Nature Reviews Cancer.

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

Peter G Schultz, Chan Hyuk Kim, Feng Tian, 2012, Proceedings of the National Academy of Sciences.

Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells

B. Felding-Habermann, J. Forsyth, M. Lorger, 2011, Journal of Neuro-Oncology.

Activation of tumor cell integrin αvβ3 controls angiogenesis and metastatic growth in the brain

B. Felding-Habermann, Joseph S. Krueger, M. Lorger, 2009, Proceedings of the National Academy of Sciences.

Platelets alter tumor cell attributes to propel metastasis: programming in transit.

Laurie J. Gay, B. Felding-Habermann, B. Felding‐Habermann, 2011, Cancer cell.

A Human Single-Chain Antibody Specific for Integrin α3β1 Capable of Cell Internalization and Delivery of Antitumor Agents

D. Boger, H. Ditzel, P. Wirsching, 2004 .

Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.

M. Hensler, B. Faha, B. Felding-Habermann, 2002, Clinical & experimental metastasis.

Involvement of tumor cell integrin αvβ3 in hematogenous metastasis of human melanoma cells

M. Hensler, B. Faha, B. Felding-Habermann, 2004, Clinical & Experimental Metastasis.

Selective Interaction of a Conformationally-constrained Arg-Gly- Asp (RGD) Motif with the Integrin Receptor αvβ3 Expressed on Human Tumor Cells

B. Felding-Habermann, Z. Ruggeri, M. Zanetti, 1997 .

Neural Stem Cell Delivery of Therapeutic Antibodies to Treat Breast Cancer Brain Metastases

B. Felding-Habermann, B. Felding‐Habermann, 2009 .

Hemostasis, Thrombosis, and Vascular Biology: Inhibition of tissue factor signaling suppresses tumor growth

Y. Takada, H. Versteeg, W. Ruf, 2014 .

Selective formation of covalent protein heterodimers with an unnatural amino acid.

P. Schultz, Stephanie A. Kazane, Vaughn V. Smider, 2011, Chemistry & biology.

Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.

S. Ferrone, P. Natali, D. Giannarelli, 1997, Cancer research.

Molecular Determinants of Arg-Gly-Asp Ligand Specificity for β3 Integrins*

B. Felding-Habermann, T. Kunicki, D. Annis, 1997, The Journal of Biological Chemistry.

Integrin Signaling in Angiogenesis and Metastatic Cancer Progression in the Brain

B. Felding-Habermann, M. Lorger, B. Felding‐Habermann, 2011 .

Maintaining and engineering neural stem cells for delivery of genetically encoded therapy to brain tumors.

E. Snyder, B. Felding-Habermann, Joseph S. Krueger, 2009, Methods in molecular biology.

A Single Immunoglobulin-like Domain of the Human Neural Cell Adhesion Molecule L1 Supports Adhesion by Multiple Vascular and Platelet Integrins

D. Cheresh, P. Brooks, M. Ginsberg, 1997, The Journal of cell biology.

Vitronectin and its receptors.

D. Cheresh, B. Felding-Habermann, B. Felding‐Habermann, 1993, Current opinion in cell biology.

Role of alpha V integrins and vitronectin in human melanoma cell growth.

D. Cheresh, B. Felding-Habermann, B. M. Mueller, 1992, Cold Spring Harbor symposia on quantitative biology.

Platelet glycoprotein Ib alpha supports experimental lung metastasis.

Masahiko Zuka, S. Russell, J. Ware, 2007, Proceedings of the National Academy of Sciences of the United States of America.

Chemically programmed antibodies targeting multiple alpha(v) integrins and their effects on tumor-related functions in vitro.

R. Lerner, B. Felding-Habermann, Sanjib K. Das, 2011, Bioconjugate chemistry.

Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression.

T. Yagi, A. Santidrián, A. Matsuno-Yagi, 2013, The Journal of clinical investigation.

Kinetic analysis of integrin-dependent cell adhesion on vitronectin--the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides.

K. Preissner, S. Goodman, T. Kirkegaard, 1998, European journal of biochemistry.

Role of 3 Integrins in Melanoma Cell Adhesion to Activated Platelets under Flow (*)

Zaverio M. Ruggeri, B. Felding-Habermann, Z. Ruggeri, 1996, The Journal of Biological Chemistry.

Integrin adhesion receptors in tumor metastasis

B. Felding-Habermann, B. Felding‐Habermann, 2004, Clinical & Experimental Metastasis.

A human single-chain antibody specific for integrin alpha3beta1 capable of cell internalization and delivery of antitumor agents.

D. Boger, H. Ditzel, P. Wirsching, 2004, Chemistry & biology.

An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation.

Peter G Schultz, Chih-yuan Chiang, A. Orth, 2010, Cell stem cell.

Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.

B. Felding-Habermann, M. Lorger, B. Felding‐Habermann, 2010, The American journal of pathology.

The Biology of Metastasis to a Sanctuary Site

P. Steeg, A. Chambers, D. Palmieri, 2007, Clinical Cancer Research.

Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells

A. Saven, J. Pilch, B. Felding-Habermann, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Integrin activation controls metastasis in human breast cancer.

J W Smith, Jeffrey W. Smith, A. Saven, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery.

Y. Liu, K. Janda, G. Kaufmann, 2007, Molecular pharmaceutics.

Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand.

Ying Liu, Kim D Janda, Bin Zhou, 2006, Biochemistry.

Adaptation of energy metabolism in breast cancer brain metastases.

J. Yates, E. Chen, Martin R. Weber, 2007, Cancer research.

Large Scale Protein Profiling by Combination of Protein Fractionation and Multidimensional Protein Identification Technology (MudPIT)*

John R Yates, Emily I Chen, J. Yates, 2006, Molecular & Cellular Proteomics.

Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.

D. Cheresh, C. Romerdahl, B. Felding-Habermann, 1992, The Journal of clinical investigation.

Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis.

Kim D Janda, Richard A Lerner, R. Lerner, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Maspin alters the carcinoma proteome

Jeffrey W. Smith, J. Yates, L. Florens, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions.

J. Pilch, B. Felding-Habermann, Rolf Habermann, 2002, The Journal of biological chemistry.

Distinct biological consequences of integrin alpha v beta 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments.

D. Cheresh, B. Felding-Habermann, Z. Ruggeri, 1992, The Journal of biological chemistry.

Platelet glycoprotein Ibα supports experimental lung metastasis

Masahiko Zuka, S. Russell, J. Ware, 2007, Proceedings of the National Academy of Sciences.

Clinical Significance of αvβ3 Integrin and Intercellular Adhesion Molecule-1 Expression in Cutaneous Malignant Melanoma Lesions

Soldano Ferrone, S. Ferrone, P. Natali, 1997 .

Unique Ability of Integrin αvβ3 to Support Tumor Cell Arrest under Dynamic Flow Conditions* 210

J. Pilch, B. Felding-Habermann, Rolf Habermann, 2002, The Journal of Biological Chemistry.

Targeting Tumor Cell-Platelet Interaction in Breast Cancer Metastasis

B. Felding-Habermann, B. Felding‐Habermann, 2003, Pathophysiology of Haemostasis and Thrombosis.

A CXCR4-targeted site-specific antibody-drug conjugate.

Ying Sun, P. Schultz, Feng Tian, 2014, Angewandte Chemie.

Site-specific coupling and sterically controlled formation of multimeric antibody fab fragments with unnatural amino acids.

P. Schultz, Stephanie A. Kazane, Vaughn V. Smider, 2011, Journal of molecular biology.

AWARD NUMBER: W81XWH-08-1-0468 TITLE: Neural Stem Cell Delivery of Therapeutic Antibodies to Treat Breast Cancer Brain Metastases

B. Felding-Habermann, B. Felding‐Habermann, 2010 .

Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.

A. Saven, J. Pilch, B. Felding-Habermann, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Phage-display selection of a human single-chain fv antibody highly specific for melanoma and breast cancer cells using a chemoenzymatically synthesized G(M3)-carbohydrate antigen.

James Paulson, Kim D Janda, Ola Blixt, 2002, Journal of the American Chemical Society.

Targeting activated integrin αvβ3 with patient-derived antibodies impacts late-stage multiorgan metastasis

G. Salvesen, K. Janda, S. Steiniger, 2010, Clinical & Experimental Metastasis.

XWH-081-0468 TITLE : Neural Stem Cell Delivery of Therapeutic Antibodies to Treat Breast Cancer Brain Metastases

B. Felding-Habermann, B. Felding‐Habermann, 2010 .